The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ALTER-H006: A phase II study of TQB2450 plus anlotinib as adjuvant therapy in hepatocellular carcinoma (HCC) with high risk of recurrence after surgical resection.
 
Xianhai Mao
No Relationships to Disclose
 
Xiaohui Duan
No Relationships to Disclose
 
Dongde Wu
No Relationships to Disclose
 
Cuncai Zhou
No Relationships to Disclose
 
Yifeng Tian
No Relationships to Disclose
 
Jinfang Zheng
No Relationships to Disclose
 
Changbo Fu
No Relationships to Disclose
 
Guohui Xu
No Relationships to Disclose
 
Yannan Bai
No Relationships to Disclose
 
Changxiong Wu
No Relationships to Disclose